Autumn Tampa

Autumn Tampa is an Analyst at EcoR1 Capital, LLC, a San Francisco-based biotechnology-focused investment fund. In this role, she conducts due diligence, financial analysis, and market research on companies and technologies within the biotech and life sciences sectors, supporting investment decisions on innovative drug development and therapeutic platforms.

Her career background includes specialist roles in investment banking at Goldman Sachs and Morgan Stanley, where she developed expertise in healthcare sector transactions, mergers and acquisitions, and capital markets. Her experience at leading investment banks enables her to analyze complex biotech business models and market opportunities with a rigorous, data-driven approach.

Autumn holds a Bachelor’s degree in Neurobiology from Harvard University, providing her with a strong scientific foundation to evaluate novel biotechnologies and therapeutics. Her professional focus spans the biotechnology and life sciences asset classes, where she leverages her interdisciplinary background to identify high-potential opportunities in drug development and biomedical innovation.